핵의학

본문글자크기
  • [Sci Rep.] Splenic uptake on FDG PET/CT correlates with Kikuchi-Fujimoto disease severity

    연세의대 / 성혜, 정용휴, 조응혁*, 구남수*

  • 출처
    Sci Rep.
  • 등재일
    2021 May 25
  • 저널이슈번호
    11(1):10836. doi: 10.1038/s41598-021-90350-z.
  • 내용

    바로가기  >

    Abstract
    Kikuchi-Fujimoto disease (KFD) is usually self-limiting, but prolonged systemic symptoms often result in frequent hospital visits, long admission durations, or missed workdays. We investigated the role of fluorine-18 fluoro-2-deoxy-D-glucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) in assessing KFD severity. We reviewed the records of 31 adult patients with pathologically confirmed KFD who underwent 18F-FDG PET/CT between November 2007 and April 2018 at a tertiary-care referral hospital. Disease severity was assessed using criteria based on clinical manifestations of advanced KFD. Systemic activated lymph nodes and severity of splenic activation were determined using semi-quantitative and volumetric PET/CT parameters. The median of the mean splenic standardized uptake value (SUVmean) was higher in patients with severe KFD than those with mild KFD (2.38 ± 1.18 vs. 1.79 ± 0.99, p = 0.058). Patients with severe KFD had more systemically activated volume and glycolytic activity than those with mild KFD (total lesion glycolysis: 473.5 ± 504.4 vs. 201.6 ± 363.5, p = 0.024). Multivariate logistic regression showed that myalgia (odds ratio [OR] 0.035; 95% confidence interval [CI] 0.001-0.792; p = 0.035), total lymph node SUVmax (cutoff 9.27; OR 24.734; 95% CI 1.323-462.407; p = 0.032), and spleen SUVmean (cutoff 1.79; OR 37.770; 95% CI 1.769-806.583; p = 0.020) were significantly associated with severe KFD. 18F-FDG PET/CT could be useful in assessing KFD severity.

     

     

    Affiliations

    Hye Seong #  1   2 , Yong Hyu Jeong #  3 , Woon Ji Lee  1 , Jun Hyoung Kim  1 , Jung Ho Kim  1 , Jin Young Ahn  1 , Su Jin Jeong  1 , Jun Yong Choi  1 , Yoon Soo Park  1 , Joon Sup Yeom  1 , Young Goo Song  1 , Arthur Cho  4 , Nam Su Ku  5
    1 Department of Internal Medicine and AIDS Research Institute, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 120-752, Republic of Korea.
    2 Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea.
    3 Department of Nuclear Medicine, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 120-752, Republic of Korea.
    4 Department of Nuclear Medicine, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 120-752, Republic of Korea. artycho@yuhs.ac.
    5 Department of Internal Medicine and AIDS Research Institute, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 120-752, Republic of Korea. smileboy9@yuhs.ac.
    #

  • 덧글달기
    덧글달기
       IP : 3.141.244.201

    등록